Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evidence Lacking On Proton Therapy For Non-Small-Cell Lung Cancer – BCBS

This article was originally published in The Gray Sheet

Executive Summary

Blue Cross Blue Shield’s Technology Evaluation Center found there is insufficient evidence that proton beam therapy improves health outcomes for patients with non-small-cell lung cancer.

You may also be interested in...



Data Lacking On Proton Therapy Vs. Traditional Radiation For Cancer - AHRQ

Particle beam radiation - also known as proton therapy - is a "promising" cancer treatment, but potential advantages over alternative radiation therapies remain unproven due to a lack of long-term comparative studies, according to a Sept. 14 Agency for Healthcare Research and Quality technical brief

Debate Stirs Over Medicare Coverage For Proton Therapy In Prostate Cancer

A private insurer is calling for CMS to issue a national non-coverage decision for proton therapy in treating prostate cancer, claiming Medicare payments will encourage rapid spread of the costly technology before there is enough clinical evidence to deem the treatment reasonable and necessary

Demand Grows For Proton Therapy Equipment Amid Calls For More Research

Burgeoning clinical adoption of resource-intensive proton radiation therapy for cancer creates unique challenges for payers, manufacturers, health care providers and patients, stakeholders say

Related Content

Topics

UsernamePublicRestriction

Register

MT030059

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel